HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells.

Abstract
The RNA-binding protein tristetraprolin (TTP) promotes rapid decay of mRNAs bearing 3' UTR AU-rich elements (ARE). In many cancer types, loss of TTP expression is observed allowing for stabilization of ARE-mRNAs and their pathologic overexpression. Here we demonstrate that histone deacetylase (HDAC) inhibitors (Trichostatin A, SAHA and sodium butyrate) promote TTP expression in colorectal cancer cells (HCA-7, HCT-116, Moser and SW480 cells) and cervix carcinoma cells (HeLa). We found that HDAC inhibitors-induced TTP expression, promote the decay of COX-2 mRNA, and inhibit cancer cell proliferation. HDAC inhibitors were found to promote TTP transcription through activation of the transcription factor Early Growth Response protein 1 (EGR1). Altogether, our findings indicate that loss of TTP in tumors occurs through silencing of EGR1 and suggests a therapeutic approach to rescue TTP expression in colorectal cancer.
AuthorsCyril Sobolewski, Sandhya Sanduja, Fernando F Blanco, Liangyan Hu, Dan A Dixon
JournalBiomolecules (Biomolecules) Vol. 5 Issue 3 Pg. 2035-55 (Aug 28 2015) ISSN: 2218-273X [Electronic] Switzerland
PMID26343742 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • EGR1 protein, human
  • Early Growth Response Protein 1
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • RNA, Messenger
  • Tristetraprolin
  • Butyric Acid
  • trichostatin A
  • Vorinostat
  • Cyclooxygenase 2
  • PTGS2 protein, human
Topics
  • Butyric Acid (pharmacology)
  • Cell Line, Tumor
  • Colorectal Neoplasms (metabolism)
  • Cyclooxygenase 2 (genetics, metabolism)
  • Early Growth Response Protein 1 (metabolism)
  • Epigenesis, Genetic
  • Histone Deacetylase Inhibitors (pharmacology)
  • Humans
  • Hydroxamic Acids (pharmacology)
  • RNA, Messenger (metabolism)
  • Tristetraprolin (genetics, metabolism)
  • Vorinostat

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: